Your session is about to expire
← Back to Search
Fostamatinib for Immune Thrombocytopenia (ITP)
Study Summary
This trial will last about 2 years.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2012 Phase 3 trial • 923 Patients • NCT01197521Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not have a severe mental illness that prevents me from understanding this study.I agree to use two forms of birth control or abstain from sex to avoid pregnancy during and for 1 month after the study.I am a man who will use two forms of birth control and not donate sperm during and for 1 month after the study.I have signs of my body rejecting a transplant, confirmed by tests.I have low blood cell counts not caused by my immune system.
- Group 1: Fostamatinib Arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Might I be eligible to take part in this research?
"This clinical trial is enrolling 20 people with anemia between the ages of 18 and 75. Most importantly, candidates must meet the following criteria: -Hemoglobin >= 9 g/dL (or at least >= 1 g/dL above baseline) in subjects enrolled with posttransplant anemia without transfusion support, at least once during the 12-week phase II trial., -OR --Platelets >= 30 X 10^9/L (or at least => 10 X 109/L above baseline) without transfusion support, at least once during the 12-week phase II trial, in subjects"
Has fostamatinib been federally certified in the United States?
"While there is some clinical data supporting the safety of fostamatinib, it has not been proven effective yet, so it received a score of 2."
Does this research include elderly individuals?
"The age parameters for this clinical trial are that patients must be at least 18 years old, and no older than 75."
Would it be possible to enroll in this research project?
"Although no longer recruiting, this trial was originally posted on 15th November 2022 and edited as recently as 9th November 2022. There are plenty of other trials actively recruiting patients right now - 144 to be precise."
Share this study with friends
Copy Link
Messenger